Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 2
1995 1
1998 1
2009 2
2010 1
2013 2
2014 2
2015 2
2016 2
2017 1
2018 2
2019 1
2020 2
2021 2
2022 3
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide: A randomized controlled trial.
Punthakee Z, Hall S, McInnes N, Sherifali D, Tsiplova K, Kirabo FR, Ransom TPP, Harris SB, Lochnan HA, Sigal RJ, Ghosh M, Spaic T, Gerstein HC; REMIT‐IDegLira Collaborative Group. Punthakee Z, et al. Among authors: lochnan ha. Diabetes Obes Metab. 2024 Dec;26(12):5600-5608. doi: 10.1111/dom.15926. Epub 2024 Sep 6. Diabetes Obes Metab. 2024. PMID: 39239702 Clinical Trial.
Facilitating the 'STEP' from junior to senior resident.
Leafloor CW, Huang AR, Code CC, Lochnan HA. Leafloor CW, et al. Among authors: lochnan ha. Med Educ. 2016 May;50(5):588-9. doi: 10.1111/medu.13013. Med Educ. 2016. PMID: 27072477 No abstract available.
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
McInnes N, Hall S, Lochnan HA, Harris SB, Punthakee Z, Sigal RJ, Hramiak I, Azharuddin M, Liutkus JF, Yale JF, Sultan F, Smith A, Otto RE, Sherifali D, Liu YY, Gerstein HC; REMIT-iGlarLixi Collaborative Group. McInnes N, et al. Among authors: lochnan ha. Diabetes Obes Metab. 2023 Nov;25(11):3347-3355. doi: 10.1111/dom.15234. Epub 2023 Aug 14. Diabetes Obes Metab. 2023. PMID: 37580972 Clinical Trial.
27 results